Clinical trial

Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers

NCT02361931

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-21

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2016-03-21Date precision: day

Registry last updated2019-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcerunresolved

Interventions

A hydrogel containing erythropoietinDRUG

Hydrogel (as a part of SOC)DRUG

Sponsors & collaborators

Remedor Biomed Ltdlead sponsor

Mapped research locations

HaifaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02361931 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.